Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03654547
Title Safety of TT-00420 Monotherapy in Patients With Advanced Solid Tumors and Triple Negative Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors TransThera Biosciences Co., Ltd
Indications

Advanced Solid Tumor

triple-receptor negative breast cancer

Therapies

TT-00420

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.